Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
JPRN |
Last refreshed on:
|
17 October 2023 |
Main ID: |
JPRN-UMIN000015125 |
Date of registration:
|
12/09/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Time in Poor Glycaemic Control in People with Type 2 Diabetes Initiating Basal Insulin Treatment: a Cohort Study in the CODIC Database
|
Scientific title:
|
Time in Poor Glycaemic Control in People with Type 2 Diabetes Initiating Basal Insulin Treatment: a Cohort Study in the CODIC Database - Time in Poor Glycaemic Control in People with Type 2 Diabetes Initiating Basal Insulin Treatment |
Date of first enrolment:
|
2014/10/01 |
Target sample size:
|
12400 |
Recruitment status: |
Complete: follow-up complete |
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017594 |
Study type:
|
Observational |
Study design:
|
Not selected Not selected
|
Phase:
|
Not selected
|
|
Countries of recruitment
|
Japan
| | | | | | | |
Contacts
|
Name:
|
Tomoe
Sumi |
Address:
|
715-1, Higashi-hiratuka, Tsukuba, Ibaraki, Japan, 305-0812
305-0812
Japan |
Telephone:
|
029-852-1882 |
Email:
|
info@jddm.jp |
Affiliation:
|
Japan Diabetes Clinical Data Manegement Study Group Office |
|
Name:
|
Jo
Satoh |
Address:
|
2-29-1 Yamatomachi, Wakabayashi-ku, Sendai, Japan 984-8560
Japan |
Telephone:
|
022-236-5803 |
Email:
|
josatoh@nifty.com |
Affiliation:
|
NTT-East Tohoku Hospital Director |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: If there is an agreement to withdraw data use, exclude the summary.
Age minimum:
18years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
Health Condition(s) or Problem(s) studied
|
Type 2 diabetes
|
Primary Outcome(s)
|
-Investigate the period between treatment changed from the start of the Basal insulin, to assess the effect of each factor by using a covariate analysis -For Basal insulin-treated patients, describes a time to make a change in therapy from the state (if more than 7.5 HbA1c value) glycemic control is not enough to assess the impact of influence each factor at the time of treatment change.
|
Source(s) of Monetary Support
|
Novo Nordisk A/S
|
Ethics review
|
Status: YES
Approval date: 24/06/2014
Contact:
info@jddm.jp
Japan Diabetes Clinical Data Manegement Study Group
03-5521-2881
info@jddm.jp
|
|